Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
128 hedge funds and large institutions have $75.5M invested in Ampio Pharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 20 closing their positions.
561% more call options, than puts
Call options by funds: $2.71M | Put options by funds: $410K
90% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 20
47% more capital invested
Capital invested by funds: $51.5M → $75.5M (+$24M)
22% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 23
16% more funds holding
Funds holding: 110 → 128 (+18)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$4.91M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.05M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.76M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.23M |
| 2 |
HF
HRT Financial
New York
|
-$839K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$817K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$794K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$662K |
AMPE Hedge Fund Activity: Q2 2021 in Review
128 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2021, worth a combined $75.5M — up 47% from $51.5M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new AMPE positions and 20 closed out — a net gain of 18 holders — while 28 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.
- 128 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2021, up from 110 in Q1 2021.
- Funds reported $75.5M of Ampio Pharmaceuticals Inc. stock for Q2 2021, up 47% quarter-over-quarter.
- 38 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2021 and 20 closed out, a net change of +18 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2021 was BlackRock, an estimated $15.4M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2021 was Millennium Management, an estimated $3.23M sold.
Based on aggregated 13F filings for Q2 2021.